JuggerStitch Post Market Clinical Follow-up Study
Completed · Not applicable · NCT04228367
Conditions: Meniscus Tear, Tibial, Meniscus Lesion
At a glance
- Research payments reported, 2025
- $1,567
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 103
About the trial
- Sponsor
- Zimmer Biomet
- Tested
- JuggerStitch Meniscal Repair Device (device)
- Dates
- Started 2020-09-25; completion 2026-05-31
- Results posted
- Yes
This study is a post-market follow-up study. The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (Instruction For Use).
From ClinicalTrials.gov, last updated 2026-09-24. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Zimmer Biomet Holdings, Inc. reported $1,567 in research payments for this study in 2025 (1 payments).
Products named: Juggerstitch
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Wcg Irb $1,567
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.